Why implement
Our PGD templates have been developed with reference to national expertise and through an established programme. They provide a consistent presentation which has been reviewed by specialists within the given area, and they ensure that the legislative and clinical parameters have been fully considered.
Template text
The templates are marked in a standard way throughout to support those implementing them.
Blue text requires local adaptation
The PGD templates may require local adaptation to reflect local policies or commissioning arrangements. Where locally adaptation is required, this is highlighted in blue.
Yellow text is advisory
Where advisory text is present, this is highlighted in yellow. Advisory text supports the adoption of the PGD, but should be removed from final versions used locally.
Signatories
Each organisation using these PGD templates must ensure they are signed by:
- a senior pharmacist
- a senior doctor
- the organisation’s governance lead
- any other professional group representatives involved in their use
Further advice on PGD signatories is available.
Local governance
PGDs must also be reviewed through the organisation’s PGD governance system prior to obtaining the governance lead’s signature.
Expiry dates
Our commitment
Our templates will be reviewed and re-released prior to reaching their expiry date. If any relevant changes occur to the product SPC or other guidance then an earlier review will also be undertaken.
Local extension
Any decision to locally extend a stated expiry date needs to be locally assessed and agreed as per the organisation’s local policy.
Process guide
A detailed implementation process guide is attached.
Update history
- Updated implementation guide published
- Link to PGD signatories article updated
- Minor update to attachment to amend CCG to ICB and PHE to UKHSA
- Published